Evidence map›Paper›PMID 35335407›Full record

ReviewPolymers2022

Recent Developments in Blood-Compatible Superhydrophobic Surfaces.

Zhiqian Wang, Sumona Paul, Louis H Stein, Arash Salemi, Somenath Mitra

Abstract readReview
In one paragraph

Review in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhiqian WangDepartment of Chemistry and Environmental Science, New Jersey Institute of Technology, 161 Warren Street, Newark, NJ 07102, USA.ORCID 0000-0001-8344-2530
Sumona PaulDepartment of Chemistry and Environmental Science, New Jersey Institute of Technology, 161 Warren Street, Newark, NJ 07102, USA.
Louis H SteinNorthern Department of Cardiothoracic Surgery, RWJBarnabas Health, 201 Lyons Avenue, Suite G5, Newark, NJ 07112, USA.
Arash SalemiNorthern Department of Cardiothoracic Surgery, RWJBarnabas Health, 201 Lyons Avenue, Suite G5, Newark, NJ 07112, USA.
Somenath MitraDepartment of Chemistry and Environmental Science, New Jersey Institute of Technology, 161 Warren Street, Newark, NJ 07102, USA.ORCID 0000-0002-9650-9180

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superhydrophobic surfaces, as indicated in the name, are highly hydrophobic and readily repel water. With contact angles greater than 150° and sliding angles less than 10°, water droplets flow easily and hardly wet these surfaces. Superhydrophobic materials and coatings have been drawing increasing attention in medical fields, especially on account of their promising applications in blood-contacting devices. Superhydrophobicity controls the interactions of cells with the surfaces and facilitates the flowing of blood or plasma without damaging blood cells. The antibiofouling effect of superhydrophobic surfaces resists adhesion of organic substances, including blood components and microorganisms. These attributes are critical to medical applications such as filter membranes, prosthetic heart valves, extracorporeal circuit tubing, and indwelling catheters. Researchers have developed various methods to fabricate blood-compatible or biocompatible superhydrophobic surfaces using different materials. In addition to being hydrophobic, these surfaces can also be antihemolytic, antithrombotic, antibacterial, and antibiofouling, making them ideal for clinical applications. In this review, the authors summarize recent developments of blood-compatible superhydrophobic surfaces, with a focus on methods and materials. The expectation of this review is that it will support the biomedical research field by providing current trends as well as future directions.

Indexed as

bio-medical applicationsblood compatiblecoatingcontact anglesuperhydrophobic

Identifiers

PMID35335407
PMCPMC8953528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.